Search

Home > News & Events > Current News

Current News

Current SATVI news

September 2019 Latest research: Plasma Type I IFN Protein Concentrations in Human Tuberculosis
Fri, 13 Sep 2019 - 23:00

SATVI researchers Professors Mark Hatherill, Tom Scriba, Dr Bilek, Darboe, Mbandi, Penn-Nicholson have co-authored a research article titled "Plasma Type I IFN Protein Concentrations in Human Tuberculosis." appearing in the Frontiers in Cellular and Infection Microbiology.

September 2019 Latest Research Non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis.
Fri, 13 Sep 2019 - 22:45

Professor Mark Hatherill has co-authored a journal article titled "FDG-PET/CT as a non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis" appearing in the Journal of Nuclear Medicine.

Latest Research: FDG-PET/CT as a non-invasive biomarker for R assessing adequacy of treatment and predicting relapse patients treated for Pulmonary Tuberculosis
Mon, 02 Sep 2019 - 15:45

Professor Mark Hatherill has co-authored a journal article titled: "FDG-PET/CT as a non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis" appearing in the Journal of Nuclear Medicine.

27 August 2019 Vacancy: Postdoctoral Fellowship TB Immunology
Tue, 27 Aug 2019 - 13:15

We are inviting applications for a postdoctoral fellowship in human immunology to conduct research aimed at identifying lung immune signatures of resistance to natural M.tb infection in a multi-cohort study.

August 2019 Latest Research Published Results MTBVAC vaccine candidate offer hope for control of tuberculosis in infants
Tue, 13 Aug 2019 - 09:30

SATVI researchers have just published an article titled: "Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial" appearing in the Lancet Respiratory Medicine journal. 

August 2019 Research: Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy
Fri, 02 Aug 2019 - 14:00
South African Tuberculosis Vaccine Initiative researchers Professors Mark Hatherill, Tom Scriba and Doctor Adam Penn-Nicholson have co-authored a research paper titled "Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy" appearing in the Scientific Reports journal.
July 2019 Research: Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state.
Fri, 26 Jul 2019 - 15:30

SATVI researcher Professor Tom Scriba has co-authored a research paper titled "Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state" appearing in the PLoS One journal.

July 2019 Detection of Tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-Infected Persons on Antiretroviral Therapy.
Fri, 26 Jul 2019 - 15:15

SATVI researchers Professors Mark Hatherill, Tom Scriba, Doctors Darboe, Penn-Nicholson, Mbandi, Nicole Bilek, SImba Mabwe have authored a research paper titled "Detection of Tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-infected persons on Antiretroviral Therapy" appearing in the Frontiers in Microbiology journal.

July 2019 Research Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol.
Fri, 26 Jul 2019 - 15:00

SATVI researchers Professors Mark Hatherill, Tom Scriba, Humphrey Mulenga and Doctors Eric Bunyase, Mbandi, Mendelsohn, Kagina and Penn-Nicholson have authored a research paper titled: "Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol" appearing in the British Medical Journal.

June 2019 Research Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents.
Fri, 26 Jul 2019 - 14:30

SATVI researchers Profesors Mark Hatherill, Tom Scriba, Doctors Bunyasi, Geldenhuys, Mulenga, Shenje, Luabeya, Tameris, Nemes, Rozot have authored a research paper titled "Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents" appearing in the International Journal of Tuberculosis and Lung Disease.

June 2019 Research Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies.
Fri, 26 Jul 2019 - 13:30

Professor Mark Hatherill has co-authored a article titled: "Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies" appearing in the Lancet Respiratory Medicine journal.

19 June 2019 Latest Keystone Symposium
Wed, 19 Jun 2019 - 13:00

Cheleka Mpande, SATVI researcher features in the latest online Keystone Symposium in which she explains the paper titled “Functional, antigen-specific stem cell memory (TSCM) CD4+ T cells are induced by human M.tuberculosis infection”

Pages